Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

Journal: Cancer Research

Published: 2020-05-01

DOI: 10.1158/0008-5472.can-19-3116

Affiliations: 15

Authors: 20

Go to article
Institutions Share
Department of Surgery, GW, United States of America (USA) 0.25
Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center, United States of America (USA) 0.15
Henry Ford Hospital, HFHS, United States of America (USA) 0.10
Pfizer Inc., United States of America (USA) 0.05
Division of Pediatrics, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.05
Georgetown Lombardi Comprehensive Cancer Center, United States of America (USA) 0.05
Department of Biochemistry and Molecular Biology, Howard University, United States of America (USA) 0.05
Department of Pathology, GW, United States of America (USA) 0.05
Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Biochemistry and Molecular Medicine, GW, United States of America (USA) 0.05
BioSerendipity, LLC, United States of America (USA) 0.03
Washington DC VA Medical Center, United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER